Inhibitor Therapeutics, Inc. SEC filings INTI
Inhibitor Therapeutics, Inc. has 724 filings in SEC EDGAR's recent list, going back to Jul 21, 1997. Its latest annual report, Form 10-K, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 18, 2026 (officer or director change, shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| POS AM | Filing | Apr 26, 2019 | — |
| POS AM | Filing | Apr 4, 2018 | — |
| POS AM | Post - effective amendment no. 1 to form s-1 | Apr 21, 2017 | — |
| S-8 | Employee stock plan registration | Oct 24, 2016 | — |
| 424B3 | Prospectus | Jul 26, 2016 | — |
| S-1/A | Amended registration statement | Jul 21, 2016 | — |
| S-1/A | Amended registration statement | Jul 18, 2016 | — |
| S-1 | Registration statement | Jun 17, 2016 | — |
| S-1/A | Amended registration statement | Feb 23, 2016 | — |
| S-1 | Registration statement | Dec 17, 2015 | — |
| 424B3 | Prospectus | Aug 10, 2015 | — |
| S-1/A | Amended registration statement | Jul 22, 2015 | — |
| S-1 | Registration statement | Sep 17, 2014 | — |
| S-1/A | Amended registration statement | Apr 30, 2008 | — |
| S-1/A | Amended registration statement | Apr 18, 2008 | — |
| S-8 | Employee stock plan registration | Jun 17, 2004 | — |
| S-3 | Shelf registration | Jun 17, 2004 | — |
| S-8 POS | Post effective amendment #1 to form s-8 | Apr 28, 2004 | — |
| S-8 | Employee stock plan registration | Jan 6, 2003 | — |
| S-8 POS | Post-effective amendment no. 1 to form s-8 | Jan 6, 2003 | — |
| S-3 | Shelf registration | Nov 22, 2002 | — |
| S-3/A | Filing | Dec 15, 2000 | — |
| S-3 | Shelf registration | Dec 1, 2000 | — |
| S-8 | Employee stock plan registration | Dec 1, 2000 | — |
| S-8 | Employee stock plan registration | May 6, 1998 | — |
| POS AM | Cbi form sb-2 post effective amendment | Feb 2, 1998 | — |
| 424B1 | Commonwealth biotechnologies, inc. 424b(1) | Oct 21, 1997 | — |
Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- INTI (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Tampa, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1042418
- Former names
- HedgePath Pharmaceuticals, Inc. (until Aug 12, 2019); COMMONWEALTH BIOTECHNOLOGIES INC (until May 20, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.